M&A News: Vertex Stock (VRTX) Slips After Announcing the $10B Crinetics Acquisition

Source Summary

Vertex Pharmaceuticals (VRTX) fell about 2.3% after hours on Monday following a deal to acquire endocrine‑focused drugmaker Crinetics Pharmaceut...